Auranta is a biotech company, based in Ireland and founded in 2013 by John Cullen and Dr. Patrick Ward.
Auranta is a spin-off from the University College Dublin Research and Innovation unit NovaUCD. Auranta’s scientific and technical expertise is a vital source of knowledge that helps us create innovative products – and retain our competitive edge.
From a business management perspective, Auranta receives valuable insights from Dr. Chris Horn, who joined our team in 2017. His experience in investing in emerging technologies on an international level has further strengthened Auranta’s commitment to its global mission of reducing antimicrobial resistance.
Auranta was established as a biotech start-up company. Today we are ready to further scale up our activities. We are therefore proud and pleased to share our milestones with you.